These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28133801)

  • 1. Anti-retroviral antibody FcγR-mediated effector functions.
    Bournazos S; Ravetch JV
    Immunol Rev; 2017 Jan; 275(1):285-295. PubMed ID: 28133801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fcγ receptor pathways during active and passive immunization.
    Bournazos S; Ravetch JV
    Immunol Rev; 2015 Nov; 268(1):88-103. PubMed ID: 26497515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversification of IgG effector functions.
    Bournazos S; Ravetch JV
    Int Immunol; 2017 Jul; 29(7):303-310. PubMed ID: 28472280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies.
    Parsons MS; Chung AW; Kent SJ
    Retrovirology; 2018 Aug; 15(1):58. PubMed ID: 30134945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc receptor-mediated antiviral antibodies.
    Forthal DN; Moog C
    Curr Opin HIV AIDS; 2009 Sep; 4(5):388-93. PubMed ID: 20048702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo.
    Wang P; Gajjar MR; Yu J; Padte NN; Gettie A; Blanchard JL; Russell-Lodrigue K; Liao LE; Perelson AS; Huang Y; Ho DD
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):18002-18009. PubMed ID: 32665438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody.
    Asokan M; Dias J; Liu C; Maximova A; Ernste K; Pegu A; McKee K; Shi W; Chen X; Almasri C; Promsote W; Ambrozak DR; Gama L; Hu J; Douek DC; Todd JP; Lifson JD; Fourati S; Sekaly RP; Crowley AR; Ackerman ME; Ko SH; Kilam D; Boritz EA; Liao LE; Best K; Perelson AS; Mascola JR; Koup RA
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18754-18763. PubMed ID: 32690707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.
    Wines BD; Billings H; Mclean MR; Kent SJ; Hogarth PM
    Curr HIV Res; 2017; 15(3):202-215. PubMed ID: 28322167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
    Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.
    Bournazos S; Klein F; Pietzsch J; Seaman MS; Nussenzweig MC; Ravetch JV
    Cell; 2014 Sep; 158(6):1243-1253. PubMed ID: 25215485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Fc Gamma Receptor Polymorphisms Important in HIV-1 Infection Outcomes and Latent Reservoir Size?
    Lamptey H; Bonney EY; Adu B; Kyei GB
    Front Immunol; 2021; 12():656894. PubMed ID: 34017334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.
    Edgar JE; Bournazos S
    Immunol Rev; 2024 Sep; ():. PubMed ID: 39268652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fcγ Receptor Function and the Design of Vaccination Strategies.
    Bournazos S; Ravetch JV
    Immunity; 2017 Aug; 47(2):224-233. PubMed ID: 28813656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.
    Lassaunière R; Musekiwa A; Gray GE; Kuhn L; Tiemessen CT
    Retrovirology; 2016 Jun; 13(1):40. PubMed ID: 27287460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.
    Lewis GK
    Curr HIV Res; 2013 Jul; 11(5):354-64. PubMed ID: 24191940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential requirements for FcγR engagement by protective antibodies against Ebola virus.
    Bournazos S; DiLillo DJ; Goff AJ; Glass PJ; Ravetch JV
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20054-20062. PubMed ID: 31484758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption.
    Billings H; Wines BD; Dyer WB; Center RJ; Trist HM; Kent SJ; Hogarth PM
    AIDS Res Hum Retroviruses; 2019 Sep; 35(9):842-852. PubMed ID: 31288562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses.
    Tay MZ; Liu P; Williams LD; McRaven MD; Sawant S; Gurley TC; Xu TT; Dennison SM; Liao HX; Chenine AL; Alam SM; Moody MA; Hope TJ; Haynes BF; Tomaras GD
    PLoS Pathog; 2016 Aug; 12(8):e1005817. PubMed ID: 27579713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent Requirement of Fc-Fcγ Receptor Interactions for
    Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.